NEA Co-leads $29.6M Round For CVRx

CVRx, Inc., a private medical device company, has completed a private equity financing totaling $29.6 million.

CVRx plans to use the funding for the primary purposes of advancing its clinical trials and expanding its international commercial activities. New Enterprise Associates, Inc. (NEA) and Johnson & Johnson Development Corporation were the co-lead investors. Other participants in this round included existing investors BBT Fund L.P. and SightLine Partners.

About the Co-Lead Investors
NEA, founded in 1978, is a leading venture capital firm focused on helping entrepreneurs create and build major new enterprises. NEA focuses on investments at all stages of a company’s development, from seed stage through IPO. With approximately $13 billion in committed capital across its affiliated funds, NEA’s experienced management team has invested in over 600 companies. For additional information, visit

Organized in 1973, Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC makes private equity investments in venture funded health care companies. Portfolio companies include those in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products. For more information, go to

Posted in and tagged with

Why Open a Browser, get citybizlist in your InBox.